The historical rank and industry rank for Beacon Pharmaceuticals's OCF Margin % or its related term are showing as below:
DHA:BEACONPHAR'
s OCF Margin % Range Over the Past 10 Years
Min: -1.68 Med: 7.64 Max: 33.27
Current: -10.58
During the past 10 years, the highest OCF Margin % of Beacon Pharmaceuticals was 33.27%. The lowest was -1.68%. And the median was 7.64%.
DHA:BEACONPHAR's OCF Margin % is ranked worse than 82.59% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs DHA:BEACONPHAR: -10.58
Beacon Pharmaceuticals OCF Margin % Related Terms
Beacon Pharmaceuticals OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:BEACONPHAR vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Beacon Pharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beacon Pharmaceuticals OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beacon Pharmaceuticals's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Beacon Pharmaceuticals's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beacon Pharmaceuticals (DHA:BEACONPHAR) has a OCF Margin % of 0.00% as of Jun. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Beacon Pharmaceuticals and its competitors. According to the industry distribution chart, Beacon Pharmaceuticals ranks #792 out of 959 companies in the Drug Manufacturers industry, placing it in the top 82.6%.
Is Beacon Pharmaceuticals' OCF Margin % too high?
Beacon Pharmaceuticals' current OCF Margin % is 0.00%. Based on the distribution chart, Beacon Pharmaceuticals ranks #792 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Beacon Pharmaceuticals has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beacon Pharmaceuticals' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Beacon Pharmaceuticals ranks #792 out of 959 companies for OCF Margin %. This places Beacon Pharmaceuticals in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Beacon Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beacon Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beacon Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Beacon Pharmaceuticals (DHA:BEACONPHAR) is currently considered Significantly Undervalued. The stock's GF Value™ is BDT384.60, compared to a current price of BDT109.90 — trading 71.4% below its estimated fair value. The current OCF Margin % is 0.00%. Beacon Pharmaceuticals' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Beacon Pharmaceuticals (DHA:BEACONPHAR), the current OCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beacon Pharmaceuticals (DHA:BEACONPHAR) Overvalued in 2026?
Based on GuruFocus' analysis, Beacon Pharmaceuticals stock appears to be undervalued.
The current stock price of BDT109.90 is trading 71.4% below its estimated GF Value™ of BDT384.60.
GuruFocus considers Beacon Pharmaceuticals to be Significantly Undervalued.
Key valuation signals for DHA:BEACONPHAR:
OCF Margin %: 0.00%
GF Value™: BDT384.60 vs. price of BDT109.90 (71.4% below fair value)
No single metric tells the full story. See the DHA:BEACONPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as Oncology, Hematology, Hepatology, Nephrology, Antibiotics, Analgesics, Anti-Diabetics, Respiratory, Cardiovascular, Dermatology, muscle relaxants, and others. The company exports its products to Asia, Africa, Europe, and Latin America. The company's products can be segmented as General, Chronic Care, Palliative, Institution, Oncology, and Biotech products.
72GF Score
Get the complete analysis for DHA:BEACONPHAR
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:BEACONPHAR has been successfully added to your 
